Gilead Sciences Inc (GILD)
67.08
+0.05
(+0.07%)
USD |
NASDAQ |
Apr 24, 16:00
67.25
+0.17
(+0.25%)
After-Hours: 04:56
Gilead Sciences Cash from Financing (TTM): -5.125B for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -5.125B |
| September 30, 2023 | -5.58B |
| June 30, 2023 | -6.179B |
| March 31, 2023 | -6.081B |
| December 31, 2022 | -6.469B |
| September 30, 2022 | -6.857B |
| June 30, 2022 | -8.266B |
| March 31, 2022 | -8.194B |
| December 31, 2021 | -8.877B |
| September 30, 2021 | -6.804B |
| June 30, 2021 | 847.00M |
| March 31, 2021 | 904.00M |
| December 31, 2020 | 770.00M |
| September 30, 2020 | -257.00M |
| June 30, 2020 | -6.896B |
| March 31, 2020 | -7.879B |
| December 31, 2019 | -7.634B |
| September 30, 2019 | -8.408B |
| June 30, 2019 | -8.794B |
| March 31, 2019 | -8.089B |
| December 31, 2018 | -12.32B |
| September 30, 2018 | -7.301B |
| June 30, 2018 | -2.23B |
| March 31, 2018 | -1.958B |
| December 31, 2017 | 3.393B |
| Date | Value |
|---|---|
| September 30, 2017 | -2.302B |
| June 30, 2017 | -1.675B |
| March 31, 2017 | -2.356B |
| December 31, 2016 | -9.725B |
| September 30, 2016 | -11.84B |
| June 30, 2016 | -7.995B |
| March 31, 2016 | -11.78B |
| December 31, 2015 | -5.884B |
| September 30, 2015 | -185.00M |
| June 30, 2015 | -12.60B |
| March 31, 2015 | -8.631B |
| December 31, 2014 | -3.025B |
| September 30, 2014 | -5.104B |
| June 30, 2014 | -274.35M |
| March 31, 2014 | 539.00M |
| December 31, 2013 | -2.544B |
| September 30, 2013 | -2.209B |
| June 30, 2013 | -1.574B |
| March 31, 2013 | -1.492B |
| December 31, 2012 | 563.00M |
| September 30, 2012 | 4.600B |
| June 30, 2012 | 4.031B |
| March 31, 2012 | 3.134B |
| December 31, 2011 | 1.764B |
| September 30, 2011 | -2.223B |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-8.877B
Minimum
Dec 2021
904.00M
Maximum
Mar 2021
-5.567B
Average
-6.804B
Median
Sep 2021
Cash from Financing (TTM) Benchmarks
| Amgen Inc | 21.05B |
| Johnson & Johnson | -15.82B |
| Eli Lilly and Co | 3.496B |
| Pfizer Inc | 26.07B |
| CymaBay Therapeutics Inc (DELISTED) | 345.77M |